Global

Jun 01, 2016
Eleanor Biggs looks at the biggest uncertainties facing the pharma industry if the UK were to leave the EU.
Jun 01, 2016
NHS England head Simon Stevens believes the UK's PPRS needs significantly updating.
May 24, 2016
Is a more "light-touch" appraisal process the key to getting the UK's NICE to do more with less? Leela Barham reports.
May 06, 2016
Pharmaceutical Executive
European pharma is bracing itself for EFPIA’s June deadline requiring the disclosure of transfer-of-value transactions make to HCPs.
May 04, 2016
The dilemma continues: Which medicines should Europe's health systems pay for – and how much should they pay?
May 02, 2016
As companies look to raise capital, selling and then leasing back real estate is a tempting option and one that other industries are utilizing, writes Karen Williamson.
Apr 04, 2016
Reflector sees both altruism and self-interest in European thinking on neglected diseases.
Mar 06, 2016
Pharmaceutical Executive
A new study spells out the many drug pricing problems in Europe just fine, but fails to address a central access issue.
Mar 01, 2016
Bruno Villetelle discusses how Japanese companies like Takeda have begun to digitize in order to care for the country's aging population.
Feb 25, 2016
As a European politician attacks abuses of the orphan drug scheme, an EU report extols its virtues. Reflector asks: in Europe, does the right hand know what the left hand is doing?
native1_300x100
lorem ipsum